BioCentury | Mar 10, 2017
Finance

Debiopharm’s new focus

...most recent was the acquisition last year of a majority stake in molecular diagnostics company GenePOC Inc....
BioCentury | Feb 9, 2017
Company News

Debiopharm sales and marketing update

...Debiopharm’s GenePOC Inc. company launched GenePOC CDiff and GenePOC GBS assays in Europe and the Middle East...
...assays in Europe and the Middle East. The in vitro diagnostic tests, which run on GenePOC’s...
...TcdB) and Group B Streptococcus , respectively. Debiopharm Group , Lausanne, Switzerland Business: Diagnostic Nora Weintraub Debiopharm Group GenePOC Inc. Clostridium...
BioCentury | Sep 5, 2016
Financial News

GenePOC completes venture financing

GenePOC Inc. , Quebec, Quebec Business: Diagnostic Date completed: 2016-08-30 Type: Venture financing Raised: Not disclosed Investor: Debiopharm Group Note: The investor “committed to investing tens of millions of dollars.” WIR Staff...
Items per page:
1 - 3 of 3
BioCentury | Mar 10, 2017
Finance

Debiopharm’s new focus

...most recent was the acquisition last year of a majority stake in molecular diagnostics company GenePOC Inc....
BioCentury | Feb 9, 2017
Company News

Debiopharm sales and marketing update

...Debiopharm’s GenePOC Inc. company launched GenePOC CDiff and GenePOC GBS assays in Europe and the Middle East...
...assays in Europe and the Middle East. The in vitro diagnostic tests, which run on GenePOC’s...
...TcdB) and Group B Streptococcus , respectively. Debiopharm Group , Lausanne, Switzerland Business: Diagnostic Nora Weintraub Debiopharm Group GenePOC Inc. Clostridium...
BioCentury | Sep 5, 2016
Financial News

GenePOC completes venture financing

GenePOC Inc. , Quebec, Quebec Business: Diagnostic Date completed: 2016-08-30 Type: Venture financing Raised: Not disclosed Investor: Debiopharm Group Note: The investor “committed to investing tens of millions of dollars.” WIR Staff...
Items per page:
1 - 3 of 3